Canakinumab Interactions
There are 510 drugs known to interact with canakinumab, along with 3 disease interactions. Of the total drug interactions, 47 are major, 454 are moderate, and 9 are minor.
- View all 510 medications that may interact with canakinumab
- View canakinumab disease interactions (3)
Most frequently checked interactions
View interaction reports for canakinumab and the medicines listed below.
- Acetaminophen-odan (acetaminophen)
- Acetylsalicylic Acid (aspirin)
- Acnomel (resorcinol / sulfur topical)
- Activated Charcoal (charcoal)
- Alcohol (contained in alcoholic beverages) (ethanol)
- Alprazolam Intensol (alprazolam)
- Aprodine (pseudoephedrine / triprolidine)
- Artificial Tears (ocular lubricant ophthalmic)
- Aspirin Buffered (aluminum hydroxide / aspirin / calcium carbonate / magnesium hydroxide)
- Aspirin Low Strength (aspirin)
- Ativan (lorazepam)
- Augmentin (amoxicillin / clavulanate)
- B-12 (cyanocobalamin)
- Breo Ellipta (fluticasone / vilanterol)
- Brilinta (ticagrelor)
- Co-trimoxazole (sulfamethoxazole / trimethoprim)
- Coenzyme Q10 (ubiquinone)
- Copper (copper gluconate)
- Cymbalta (duloxetine)
- Glycerol (glycerin)
- Keflex (cephalexin)
- Lipitor (atorvastatin)
- Metoprolol Succinate ER (metoprolol)
- Metoprolol Tartrate (metoprolol)
- Paracetamol (acetaminophen)
- Plavix (clopidogrel)
- Quercetin (bioflavonoids)
- Ubrelvy (ubrogepant)
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
Canakinumab disease interactions
There are 3 disease interactions with canakinumab which include:
Report options
QR code containing a link to this page
More about canakinumab
- canakinumab consumer information
- Compare alternatives
- Reviews (5)
- Side effects
- Dosage information
- During pregnancy
- Drug class: interleukin inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
